FILE - In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. (Gilead Sciences via AP)

Health Canada approves remdesivir for treatment of severe COVID-19

First drug authorized by the agency to treat the virus

Health Canada has authorized the use of drug remdesivir to treat severe symptoms of COVID-19, the agency said Tuesday (July 28).

The antiviral drug, manufactured by Gilead Sciences Canada, Inc., is the first treatment authorized for patients with serious symptoms of the virus in Canada. The drug is currently only approved for use in adults and teens aged 12 and up with a weight of at least 40 kilograms. It is not authorized for use in children or pregnant women, and is administered intravenously to treat patients with pneumonia requiring supplemental oxygen.

Canada is not the first to approve the use of remdesivir for COVID-19; the drug has been approved for use in U.S., Europe, Japan, Singapore and Australia. So far, the agency said a “small number” of patients are being treated with the drug under the Special Access Program, which will not be required for new patients going forward.

Health Canada said it completed an expedited six-week review to determine the drug’s benefits outweigh its risks when it comes to COVID-19. Two existing clinical trials are ongoing to evaluate the safety and efficacy of remdesivir. According to the European Medicines Agency, the most common side effect in healthy volunteers are increased blood levels of liver enzymes, and nausea in COVID-19 patients.

ALSO READ: B.C. sets limits on number of guests, visitors in vacation rentals, houseboats

ALSO READ: B.C. records 81 more cases of COVID-19 in B.C. in three days


@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

July Kootenay real estate sales at record high

Sales and prices of Kootenay real estate on the rise

Smoker Farms bringing craft-style cannabis to Beaverdell

Husband-wife team growing small-scale cultivations of marijuana

RCMP investigating alleged pellet gun shooting

Those involved are considered well known to Grand Forks RCMP

Maintain your yards, advises Grand Forks Fire Department

Short grass kept Aug. 2 camper fire from spreading

Grand Forks RCMP report more calls in 2020

July this year saw 15 per cent more calls compared to 2019

VIDEO: U.S. Air Force pilot does fly-by for B.C. son amid COVID border separation

Sky-high father-son visit plays out over White Rock Pier

B.C. wildfire crews have battled 111 blazes in the last seven days

Twenty-nine fires remain active, as of Friday (Aug 7)

‘We don’t make the rules’: Okanagan pub owner says staff harassed over pandemic precautions

‘If you have six people plus a baby, guess what? That’s seven’ - West Kelowna Kelly O’Bryan’s owner

T-Rex earns big bids at B.C. dino auction

Over 500 dino-themed lots sold to buyers from across North America

Remembering Brent Carver: A legend of Broadway who kept his B.C. roots strong

Over the years, the Cranbrook thespian earned his place as one of Canada’s greatest actors

Statistics Canada says country gained 419,000 jobs in July

National unemployment rate was 10.9 per cent in July, down from the 12.3 per cent recorded in June

Canada plans $3.6 billion in retaliatory tariffs on U.S. in aluminium dispute

The new Canada-United States-Mexico Agreement that replaced NAFTA went into force on July 1

Canada ‘profoundly concerned’ over China death sentence for citizen in drug case

Police later confiscated more than 120 kilograms of the drug from Xu Weihong’s home

Answers to 5 common questions facing families for the COVID-19 school year

COVID-19 protocols are likely to vary even more at the school board level, and even and school-to-school.

Most Read